Skip to main content
. 2023 Mar 14;2023:4427873. doi: 10.1155/2023/4427873

Table 2.

Levels of circulating leptin and adiponectin in different subgroups of patients hospitalized with COVID-19.

Leptin (ng/mL), median [IQR] Adiponectin (µg/mL), median [IQR]
Age
 ≤60 years 8.2 [4.0, 12.4] 7.0 [4.5, 9.0]
 61–80 years 7.8 [4.2, 13.9] 10.5 [5.6, 16.2]
 ≥81 years 6.0 [2.6, 13.3] 13.5 [7.3, 20.2]
 p value 0.37 <0.001
Sex
 Female 12.2 [4.9, 22.6] 12.5 [6.2, 18.8]
 Male 5.7 [2.9, 10.2] 8.0 [5.1, 10.8]
 p value <0.001 0.01
Hypertension
 Yes 7.4 [3.8, 12.9] 10.6 [6.9, 17.7]
 No 6.2 [3.4, 14.3] 7.6 [4.3, 12.9]
 p value 0.97 <0.01
AMI and/or heart failure
 Yes 6.8 [3.9, 11.8] 8.2 [3.7, 9.2]
 No 7.2 [3.8, 13.5] 9.0 [5.7, 14.6]
 p value 0.81 0.23
Diabetes
 Yes 6.9 [3.3, 12.8] 7.2 [3.8, 10.6]
 No 7.2 [3.8, 14.0] 9.4 [6.1, 15.6]
 p value 0.70 0.03
COPD
 Yes 4.6 [3.8, 15.9] 14.8 [11.5, 21.2]
 No 7.3 [3.7, 13.0] 8.9 [5.0, 14.2]
 p value 0.84 0.02
Asthma
 Yes 8.6 [5.6, 12.1] 10.2 [6.3, 15.7]
 No 6.6 [3.4, 13.5] 8.9 [5.1, 14.5]
 p value 0.48 0.51
Infiltration on chest X-ray
 Yes 7.1 [3.8, 13.5] 9.0 [5.1, 15.6]
 No 8.1 [3.5, 13.0] 8.3 [6.1, 10.6]
 p value 0.94 0.42
Supplemental oxygen at admission
 Yes 7.3 [4.5, 14.0] 9.2 [6.1, 14.4]
 No 7.0 [2.8, 12.3] 8.5 [5.2, 14.6]
 p value 0.21 0.93

AMI: acute myocardial infarction; COPD: chronic obstructive pulmonary disease.